Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
The proxy statement of Kura Oncology, Inc. reports total compensation of $2,669,238 for Brian Powl in fiscal 2025, including a base salary of $506,348. Brian Powl has spoken on 1 investor event across 1 company, most recently for Kura Oncology, Inc. on September 16, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Proxy statement
Start not stated–present
Proxy statement
Start not stated–2023-04-21
Last confirmed by a filing; no departure on record
Recorded roles and call appearances connecting this person to public companies.
KURA
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Kura Oncology, Inc. (KURA) | Chief Commercial Officer | $506,348 | $2,669,238 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
